3D Echocardiography Volumetric Measurements in Patients with or without Valvular Heart Disease


About this study

The purpose of this study is to determine if 3D volumetric measurements will allow more robust quantification of valvular heart disease severity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

Patients undergoing routine echocardiography

Exclusion Criteria:

  • Subjects with poor apical images
  • Patients with congenital heart anomalies
  • Patients with multivalvular disease



Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sorin Pislaru, M.D., Ph.D.

Open for enrollment

Contact information:

Sorin Pislaru M.D., Ph.D.


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer